AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
RAMIPRIL in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RAMIPRIL IMPACT 2.5MG TABLET; ORAL | 2025/12.3.5/7198 | SANOFI - AVENTIS | active | 12 Nov 2030 |
| RAMIPRIL IMPACT 5MG TABLET; ORAL | 2025/12.3.5/7199 | SANOFI - AVENTIS | active | 12 Nov 2030 |
| RAMIPRIL IMPACT 10MG TABLET; ORAL | 2025/12.3.5/7200 | SANOFI - AVENTIS | active | 12 Nov 2030 |
| TOPRIL-5 CAPSULE; ORAL | 2007/13.3.5/4511 | TORRENT PHARMACEUTICALS | active | 31 Dec 2027 |
RAMIPRIL — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing RAMIPRIL, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track RAMIPRIL registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.